Syneos Health Stock Earnings Per Share
| SYNHDelisted Stock | USD 42.31 0.07 0.17% |
Syneos Health fundamentals help investors to digest information that contributes to Syneos Health's financial success or failures. It also enables traders to predict the movement of Syneos Stock. The fundamental analysis module provides a way to measure Syneos Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Syneos Health stock.
Syneos |
Syneos Health Company Earnings Per Share Analysis
Syneos Health's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Syneos Health Earnings Per Share | 0.70 X |
Most of Syneos Health's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Syneos Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, Syneos Health has an Earnings Per Share of 0.7 times. This is 91.64% lower than that of the Life Sciences Tools & Services sector and 26.32% lower than that of the Health Care industry. The earnings per share for all United States stocks is 77.56% higher than that of the company.
Syneos Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Syneos Health's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Syneos Health could also be used in its relative valuation, which is a method of valuing Syneos Health by comparing valuation metrics of similar companies.Syneos Health is currently under evaluation in earnings per share category among its peers.
Syneos Fundamentals
| Return On Equity | 0.0209 | |||
| Return On Asset | 0.0263 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 7.23 B | |||
| Shares Outstanding | 103.72 M | |||
| Shares Owned By Insiders | 0.48 % | |||
| Shares Owned By Institutions | 94.74 % | |||
| Number Of Shares Shorted | 6.76 M | |||
| Price To Earning | 18.05 X | |||
| Price To Book | 1.07 X | |||
| Price To Sales | 0.66 X | |||
| Revenue | 5.39 B | |||
| Gross Profit | 1.25 B | |||
| EBITDA | 699.99 M | |||
| Net Income | 266.5 M | |||
| Cash And Equivalents | 124.2 M | |||
| Cash Per Share | 1.21 X | |||
| Total Debt | 2.9 B | |||
| Debt To Equity | 0.93 % | |||
| Current Ratio | 1.10 X | |||
| Book Value Per Share | 33.69 X | |||
| Cash Flow From Operations | 426.98 M | |||
| Short Ratio | 5.59 X | |||
| Earnings Per Share | 0.70 X | |||
| Price To Earnings To Growth | 1.28 X | |||
| Target Price | 42.5 | |||
| Number Of Employees | 28.77 K | |||
| Beta | 1.58 | |||
| Market Capitalization | 4.43 B | |||
| Total Asset | 8.2 B | |||
| Retained Earnings | 167.69 M | |||
| Working Capital | 219.25 M | |||
| Current Asset | 1.09 B | |||
| Current Liabilities | 1.07 B | |||
| Z Score | 1.92 | |||
| Net Asset | 8.2 B |
About Syneos Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Syneos Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Syneos Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Syneos Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Syneos Stock
If you are still planning to invest in Syneos Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Syneos Health's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |